A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : FDG

Search Conditions:
Search Keyword : FDG
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: FDG
Appearance Frequency: 5775 time(s)
Long forms: 77

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
fluorodeoxyglucose
(5637 times)
Nuclear Medicine
(1329 times)
PET (3096 times)
CT (1032 times)
PET/CT (546 times)
0 [Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature].
fluorescein di-beta-D-galactopyranoside
(23 times)
Biochemistry
(4 times)
beta-Gal (2 times)
FMG (2 times)
SA-betaG (2 times)
1990 Reliable transient promoter assay using fluorescein-di-beta-D-galactopyranoside substrate.
fluorine-18-labeled deoxyglucose
(17 times)
Neoplasms
(4 times)
PET (12 times)
CT (2 times)
CSP (1 time)
1987 Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
F-FDG
(8 times)
Nuclear Medicine
(5 times)
AUCs (1 time)
mCR (1 time)
MIRD (1 time)
2004 Evaluation of anesthesia effects on [18F]FDG uptake in mouse brain and heart using small animal PET.
18F-FDG
(5 times)
Nuclear Medicine
(3 times)
GTV (1 time)
LN (1 time)
Met (1 time)
1996 Hyperperfusion and hypermetabolism in brain radiation necrosis with epileptic activity.
18-F-labeled deoxy-glucose
(4 times)
Science
(1 time)
PET (4 times)
MRI (2 times)
5-HTP (1 time)
1997 [Cerebral positron emission tomographic study in systemic lupus erythematosus].
FES and 2-((18)F)fluoro-2-deoxy-D: -glucose
(4 times)
Nuclear Medicine
(3 times)
PET (3 times)
AD (1 time)
ER (1 time)
2003 Synthesis and evaluation of O-(3-[18F]fluoropropyl)-L-tyrosine as an oncologic PET tracer.
fluid dynamic gauging
(3 times)
Toxicology
(1 time)
CFD (1 time)
HA (1 time)
TOC (1 time)
2007 Structure and shear strength of microbial biofilms as determined with confocal laser scanning microscopy and fluid dynamic gauging using a novel rotating disc biofilm reactor.
focus group discussion
(3 times)
Emergency Medicine
(1 time)
DoBE (1 time)
LS (1 time)
MCH (1 time)
2015 Improving Five-level Triage Form According to the Experts Viewpoint; A Qualitative Study.
10  18F-labeled-Fluoro-2-Deoxy-D-Glucose
(2 times)
Biophysics
(1 time)
CRP (1 time)
CTE (1 time)
ESR (1 time)
1996 Evaluation of ion-implanted-silicon detectors for use in intraoperative positron-sensitive probes.
11  fluorine-18 deoxyglucose positron emission tomography
(2 times)
Diagnostic Imaging
(1 time)
CRLM (1 time)
EBUS-TBNA (1 time)
2009 EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes-an international multi-centre experience.
12  fusion of 2-deoxy-2-(18F)fluoro-D-glucose
(2 times)
Diagnostic Imaging
(2 times)
CT (2 times)
PET (2 times)
ICM (1 time)
2003 PET/CT using 2-deoxy-2-[18F]fluoro-D-glucose for the evaluation of suspected infected vascular graft.
13  (F-18)-fluorinated deoxyglucose
(1 time)
Neurology
(1 time)
PET (1 time)
2001 Anterior cingulate metabolism correlates with stroop errors in paranoid schizophrenia patients.
14  10-fold increase of 2-deoxy-2(18F)fluoro-D-glucose
(1 time)
Medicine
(1 time)
NIDDM (1 time)
1996 The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
15  18-fluoro deoxyglucose uptake
(1 time)
Neoplasms
(1 time)
PET (1 time)
SUV (1 time)
2016 Positron emission tomography thyroid incidentaloma: Is it different in Indian subcontinent?
16  18F-fluorodeoxyglucose method
(1 time)
Neurology
(1 time)
LCMRglc (1 time)
PET (1 time)
1983 Positron emission tomographic studies of sensory stimuli, cognitive processes and anxiety.
17  2-deoxy-2-fluoro-D-glucose labelled with fluorine
(1 time)
Nuclear Medicine
(1 time)
--- 2001 PET imaging in breast cancer.
18  2-Fluoro-((18)F)-2-deoxy-glucose
(1 time)
Diagnostic Imaging
(1 time)
FDG-6-P (1 time)
PET (1 time)
2003 Tissue-specific differences in 2-fluoro-2-deoxyglucose metabolism beyond FDG-6-P: a 19F NMR spectroscopy study in the rat.
19  2-fluoro-((18)F)-deoxy-2-D-glucose
(1 time)
Dermatology
(1 time)
CT (1 time)
MCC (1 time)
2013 Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women's Cancer Center.
20  5-formyluracil-DNA glycosylase
(1 time)
Biochemistry
(1 time)
--- 2003 Identification and characterization of mammalian 5-formyluracil-DNA glycosylase.
21  F-18-FDG-PET
(1 time)
Nuclear Medicine
(1 time)
ASY (1 time)
BRD (1 time)
CPS (1 time)
1998 PET and SPECT in medically non-refractory complex partial seizures. Temporal asymmetries of glucose consumption, benzodiazepine receptor density, and blood flow.
22  F-2'-deoxy-2'-fluorodeoxyglucose
(1 time)
Nanomedicine
(1 time)
BM (1 time)
FL (1 time)
LAT1 (1 time)
2016 11C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement.
23  F-tracers other than 2-deoxy-2-(18F)fluoro-D-glucose
(1 time)
Biology
(1 time)
IAEA (1 time)
PET (1 time)
2010 Fluorine-18 radiopharmaceuticals beyond [18F]FDG for use in oncology and neurosciences.
24  F. delphinoides strain GPK
(1 time)
Biochemistry
(1 time)
alpha-KG (1 time)
GC (1 time)
IAA (1 time)
2013 Indole-3-acetic acid biosynthesis in Fusarium delphinoides strain GPK, a causal agent of Wilt in Chickpea.
25  factors associated with a reduction in 18fluoro-2-deoxy-D-glucose
(1 time)
Nuclear Medicine
(1 time)
CRT (1 time)
PET-CT (1 time)
SRR-N (1 time)
2016 Immunohistochemical overexpression of hypoxia-induced factor 1alpha associated with slow reduction in 18fluoro-2-deoxy-D-glucose uptake for chemoradiotherapy in patients with pharyngeal cancer.
26  False-positive uptake on 2-(⁸F)-fluoro-2-deoxy-D-glucose
(1 time)
Radiology
(1 time)
PET/CT (1 time)
2011 False-positive uptake on 2-[⁸F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging.
27  faster decline in parietal Fludeoxyglucose
(1 time)
Brain
(1 time)
HC (1 time)
PET (1 time)
2012 CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects.
28  FCH was evaluated in relationship to 2-(18F)fluoro-2-deoxyglucose
(1 time)
Neoplasms
(1 time)
PET (1 time)
2001 Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.
29  FDG metabolic rate (MRFDG) divided by the LC
(1 time)
Nuclear Medicine
(1 time)
--- 1998 Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
30  FDG requires knowing the LC
(1 time)
Nuclear Medicine
(1 time)
--- 1998 Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
31  FDG/PET studies of gliomas represent regions where MRGlc, LC
(1 time)
Nuclear Medicine
(1 time)
--- 1998 Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
32  FDGint
(1 time)
Neoplasms
(1 time)
CRT (1 time)
PET (1 time)
2017 Interim 18F-FDG PET/CT During Chemoradiation Therapy in the Management of Head and Neck Cancer Patients: A Systematic Review.
33  feasibility of 2-18F-2-deoxy-D-glucose
(1 time)
Otolaryngology
(1 time)
DAR (1 time)
PET (1 time)
TAC (1 time)
1997 Positron emission tomographic imaging of head and neck lesions.
34  feasibility of imaging plaques with 2-deoxy-2-((18)F)fluoroglucose
(1 time)
Diagnostic Techniques, Cardiovascular
(1 time)
TBR (1 time)
2014 Increased microvascularization and vessel permeability associate with active inflammation in human atheromata.
35  feasibility of serial quantitative 2-deoxy-2-(18F)fluoro-D-glucose
(1 time)
Cardiology
(1 time)
gMVP (1 time)
MVP (1 time)
PET (1 time)
2017 The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis.
36  feasibility of ⁸F-fluorodeoxyglucose
(1 time)
Complementary Therapies
(1 time)
AFP (1 time)
HCC (1 time)
PET/CT (1 time)
2014 [Feasibility study of ⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in proposing selection criteria for patients with hepatocellular carcinoma in liver transplantation].
37  feature of ((18)F)fluoro-2-deoxy-d-glucose
(1 time)
Neurology
(1 time)
PSP (1 time)
2004 Midbrain hypometabolism as early diagnostic sign for progressive supranuclear palsy.
38  FES images with those based on the metabolic probe 2-(18F)fluoro-2-deoxyglucose
(1 time)
Neoplasms
(1 time)
PET (1 time)
1997 The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer.
39  few data characterizing fluorodeoxyglucose
(1 time)
Pulmonary Medicine
(1 time)
HU (1 time)
2004 Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis.
40  FJND + DDP group
(1 time)
Biomedical Technology
(1 time)
CG (1 time)
FG (1 time)
FJND (1 time)
2015 Effects of Feijining Decoction on vascular endothelial growth factor protein expression and changes of T cell subsets in Lewis lung carcinoma-bearing mice.
41  flow (((13)N)-ammonia) and 2-((18)F)fluoro-2-deoxy-D-glucose
(1 time)
Cardiology
(1 time)
CP (1 time)
Cx (1 time)
2002 Glucose uptake and glycogen levels are increased in pig heart after repetitive ischemia.
42  flow ((15O) water), blood volume ((11C)CO), 2-deoxy-2-(18F)fluoro-D-glucose
(1 time)
Diagnostic Imaging
(1 time)
AIPC (1 time)
PSA (1 time)
2003 Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer.
43  flow and increases in the uptake of 18F-2-deoxyglucose
(1 time)
Cardiology
(1 time)
LAD (1 time)
1997 18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium.
44  fludeoxyglucose F18-labeled
(1 time)
Nervous System Diseases
(1 time)
FHS-CVD (1 time)
PET (1 time)
2018 Interactive Associations of Vascular Risk and beta-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.
45  fluoride, the metabolic agents 2-(⁸F)fluoro-2-deoxy-D-glucose
(1 time)
Chemistry
(1 time)
PCa (1 time)
PET (1 time)
PSA (1 time)
2010 Radionuclide based imaging of prostate cancer.
46  Fluorine-18-Fluoro-D-glucose
(1 time)
Nuclear Medicine
(1 time)
CT (1 time)
PET (1 time)
2009 Breast cancer therapy: the role of PET-CT in decision making.
47  fluoro-2-deoxyglucose mapping
(1 time)
Behavioral Sciences
(1 time)
AAF (1 time)
AI (1 time)
1995 Mapping of stimulus features and meaning in gerbil auditory cortex with 2-deoxyglucose and c-Fos antibodies.
48  fluorodeoxyglucose labelled with fluorine-18
(1 time)
Internal Medicine
(1 time)
CT (1 time)
PET (1 time)
2014 Appropriate use of positron emission tomography with [(18)F]fluorodeoxyglucose for staging of oncology patients.
49  fluorodeoxyglucose positron
(1 time)
Brain
(1 time)
HRMRI (1 time)
2005 Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging.
50  focal intense 2-deoxy-2-((18)F)fluoro-d-glucose
(1 time)
Otolaryngology
(1 time)
PET (1 time)
2012 Suture granuloma showing false-positive finding on PET/CT after head and neck cancer surgery.
51  foci of brain, we used 2-deoxy-2-((18)F)fluoro-D-glucose
(1 time)
Medicine
(1 time)
--- 2014 Effects of metformin on the cerebral metabolic changes in type 2 diabetic patients.
52  Focus Discussion Group
(1 time)
Preventive Medicine
(1 time)
FMEA (1 time)
RPN (1 time)
2013 Clinical risk assessment in intensive care unit.
53  followed by reaction with a tetrazine-labeled-18F-2-deoxyfluoroglucose
(1 time)
Chemical Phenomena
(1 time)
TCO (1 time)
2015 The use of 18F-2-fluorodeoxyglucose (FDG) to label antibody fragments for immuno-PET of pancreatic cancer.
54  Fondazione Don Carlo Gnocchi
(1 time)
Physical and Rehabilitation Medicine
(1 time)
--- 2018 Robotic and Sensor Technology for Upper Limb Rehabilitation.
55  football + diet group
(1 time)
Sports Medicine
(1 time)
DG (1 time)
diet (1 time)
T2D (1 time)
2014 Positive effects of football on fitness, lipid profile, and insulin resistance in Brazilian patients with type 2 diabetes.
56  formaldehyde dehydrogenase
(1 time)
Nutritional Sciences
(1 time)
--- 1992 [The effect of milk consumption on the activity of the formaldehyde detoxification system in sensitization to this compound].
57  formation during hypoxia-reoxygenation in living brain tissues using 2-(18F)fluoro-2-deoxy-D-glucose
(1 time)
Brain
(1 time)
--- 2006 Development of real-time bioradiographic system for functional and metabolic imaging in living brain tissue.
58  fossa brain tumors were studied with 2-(18F)fluoro-2-deoxy-D-glucose
(1 time)
Radiology
(1 time)
PET (1 time)
1992 FDG-PET in pediatric posterior fossa brain tumors.
59  four anesthetic protocols on normal canine brain uptake of 2-deoxy-2-(18F)fluoro-D-glucose
(1 time)
Diagnostic Imaging
(1 time)
PET/CT (1 time)
SUV (1 time)
2010 Effects of anesthetic protocol on normal canine brain uptake of 18F-FDG assessed by PET/CT.
60  fractions of the liver investigated the activity of phosphatdependent glutaminase
(1 time)
Pharmacology
(1 time)
GDG (1 time)
GS (1 time)
PH (1 time)
2017 [Influence of partial hepatectomie on ammoniumdetoxications function of liver at chronic tetrachlorcarbon hepatitis].
61  freeze-dried and ground
(1 time)
Microbiological Phenomena
(1 time)
FM (1 time)
LAM (1 time)
RUSITEC (1 time)
2017 The Type of Forage Substrate Preparation Included as Substrate in a RUSITEC System Affects the Ruminal Microbiota and Fermentation Characteristics.
62  Freeze-dried gelatin
(1 time)
Biochemistry
(1 time)
SDG (1 time)
VDG (1 time)
2019 Influence of spray-drying, freeze-drying and vacuum-drying on physicochemical and functional properties of gelatin from Labeo rohita swim bladder.
63  Frequency Difference Gating
(1 time)
Cell Biology
(1 time)
rHuEPO (1 time)
SUG (1 time)
2008 Sequential univariate gating approach to study the effects of erythropoietin in murine bone marrow.
64  frequently applied radiotracer was the glucose analogue 2-((18)F)fluoro-2-deoxy- D-glucose
(1 time)
Nuclear Medicine
(1 time)
PET (1 time)
2002 A survey of PET activity in Germany during 1999.
65  frequently has low 2-(18F)fluoro-D-glucose
(1 time)
Vascular Diseases
(1 time)
--- 2006 Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma.
66  frequently used PET tracer in oncology, 2-(18F)fluoro-2-deoxyglucose
(1 time)
Biotechnology
(1 time)
--- 2012 Apoptosis imaging to monitor cancer therapy: the road to fast treatment evaluation?
67  fU-DNA glycosylase
(1 time)
Biochemistry
(1 time)
ds (1 time)
fU (1 time)
hmU (1 time)
2003 Mammalian 5-formyluracil-DNA glycosylase. 1. Identification and characterization of a novel activity that releases 5-formyluracil from DNA.
68  function, perfusion and 18F-2-deoxyglucose
(1 time)
Cardiology
(1 time)
LAD (1 time)
2001 Stability of hibernating myocardium in pigs with a chronic left anterior descending coronary artery stenosis: absence of progressive fibrosis in the setting of stable reductions in flow, function and coronary flow reserve.
69  functional imaging using non-2-deoxy-2-(18F)fluoro-D-glucose
(1 time)
Nuclear Medicine
(1 time)
--- 2016 New radiotracers in gynecological cancer: beyond ⁸F-FDG.
70  functioning of the brain, and ((18)F)fluoro-2-deoxyglucose
(1 time)
Brain
(1 time)
ETC (1 time)
FCD (1 time)
GFAP (1 time)
2014 Cerebral glucose hypometabolism is associated with mitochondrial dysfunction in patients with intractable epilepsy and cortical dysplasia.
71  fungal lesions can have remarkably high intensity uptake of 2-deoxy-2-(18F)fluoro-D-glucose
(1 time)
Diagnostic Imaging
(1 time)
PET (1 time)
SUV (1 time)
2002 Characterization of uptake of 2-deoxy-2-[18F] fluoro-D-glucose by fungal-associated inflammation: the standardized uptake value is greater for lesions of blastomycosis than for lymphoma in dogs with naturally occurring disease.
72  Furthermore, 2-((18)F)fluor-2-deoxyglucose
(1 time)
Hematology
(1 time)
DLBCL (1 time)
EFS (1 time)
OS (1 time)
2010 Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP.
73  Furthermore, dynamic F-18 Fluorodeoxyglucose
(1 time)
Nuclear Medicine
(1 time)
--- 2011 Pharmacokinetic studies of ⁶⁸Ga-labeled Bombesin (⁶⁸Ga-BZH₃) and F-18 FDG PET in patients with recurrent gliomas and comparison to grading: preliminary results.
74  fusion prior discectomy group
(1 time)
Spine
(1 time)
ADG (1 time)
ANG (1 time)
ASG (1 time)
2009 Prospective, Randomized, Multicenter FDA IDE Study of CHARITE Artificial Disc versus Lumbar Fusion: Effect at 5-year Follow-up of Prior Surgery and Prior Discectomy on Clinical Outcomes Following Lumbar Arthroplasty.
75  fuzzy deduction graph
(1 time)
Biomedical Engineering
(1 time)
FRP (1 time)
1996 Knowledge representation using fuzzy deduction graphs.
76  intravenous18-fluoro-2-deoxyglucose
(1 time)
Ophthalmology
(1 time)
PET/CT (1 time)
2005 Whole body PET/CT for initial staging of choroidal melanoma.
77  parameters-fluorodeoxyglucose
(1 time)
General Surgery
(1 time)
AGI (1 time)
NPVs (1 time)
PPVs (1 time)
2015 Modest utility of quantitative measures in (18)F-fluorodeoxyglucose positron emission tomography scanning for the diagnosis of aortic prosthetic graft infection.